Rtw Investments, LP Madrigal Pharmaceuticals, Inc. Transaction History
Rtw Investments, LP
- $5.99 Billion
- Q2 2024
A detailed history of Rtw Investments, LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,915,862 shares of MDGL stock, worth $463 Million. This represents 8.96% of its overall portfolio holdings.
Number of Shares
1,915,862
Previous 397,047
382.53%
Holding current value
$463 Million
Previous $106 Million
406.24%
% of portfolio
8.96%
Previous 1.7%
Shares
5 transactions
Others Institutions Holding MDGL
# of Institutions
297Shares Held
22MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$601 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$497 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$477 Million7.35% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$447 Million39.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$437 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...